Yasmeen Rahimi
Stock Analyst at Piper Sandler
(4.02)
# 527
Out of 4,944 analysts
82
Total ratings
43.75%
Success rate
14.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PLRX Pliant Therapeutics | Maintains: Overweight | $17 → $4 | $1.60 | +150.00% | 2 | Aug 8, 2025 | |
| VRNA Verona Pharma | Maintains: Overweight | $76 → $160 | $105.20 | +52.09% | 3 | Jun 23, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $24.05 | +224.32% | 1 | Jun 12, 2025 | |
| PRTA Prothena Corporation | Maintains: Overweight | $110 → $81 | $8.05 | +906.21% | 3 | May 27, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $81.14 | +78.70% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $13.73 | +271.45% | 4 | Apr 2, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $1.11 | +440.54% | 2 | Mar 7, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Overweight | $48 | $9.08 | +428.93% | 1 | Feb 28, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Overweight | $93 | $40.30 | +130.77% | 1 | Jan 23, 2025 | |
| UPB Upstream Bio | Initiates: Overweight | $75 | $18.55 | +304.31% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $25.72 | +308.24% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $25.76 | +43.63% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $1.59 | +1,535.22% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.83 | +3,276.34% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $30.09 | +222.37% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $49.05 | +450.46% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $22.08 | +244.28% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $3.74 | +568.45% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $12.51 | +139.81% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $5.45 | +120.18% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $4.41 | +1,940.82% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $18.93 | +850.87% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $1.97 | +661.42% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $373.46 | -10.03% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $2.70 | +492.59% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $20.74 | +285.82% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $19.16 | +385.39% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $22.22 | +192.53% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $15.89 | +258.72% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $9.58 | +599.37% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $56.72 | -38.29% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $7.60 | +1,044.74% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $7.65 | +2,187.58% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $36.88 | +95.23% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $9.14 | +107.88% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $2.85 | +1,654.39% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $0.86 | +4,545.22% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.38 | +4,651.85% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $14.90 | +2,718.79% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $19.21 | +300.83% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $65.14 | +18.21% | 1 | Jul 31, 2020 |
Pliant Therapeutics
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.60
Upside: +150.00%
Verona Pharma
Jun 23, 2025
Maintains: Overweight
Price Target: $76 → $160
Current: $105.20
Upside: +52.09%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $24.05
Upside: +224.32%
Prothena Corporation
May 27, 2025
Maintains: Overweight
Price Target: $110 → $81
Current: $8.05
Upside: +906.21%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $81.14
Upside: +78.70%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $13.73
Upside: +271.45%
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.11
Upside: +440.54%
Avalo Therapeutics
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $9.08
Upside: +428.93%
Bright Minds Biosciences
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $40.30
Upside: +130.77%
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $18.55
Upside: +304.31%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $25.72
Upside: +308.24%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $25.76
Upside: +43.63%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $1.59
Upside: +1,535.22%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.83
Upside: +3,276.34%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $30.09
Upside: +222.37%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $49.05
Upside: +450.46%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $22.08
Upside: +244.28%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $3.74
Upside: +568.45%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $12.51
Upside: +139.81%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $5.45
Upside: +120.18%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $4.41
Upside: +1,940.82%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $18.93
Upside: +850.87%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $1.97
Upside: +661.42%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $373.46
Upside: -10.03%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $2.70
Upside: +492.59%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $20.74
Upside: +285.82%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $19.16
Upside: +385.39%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $22.22
Upside: +192.53%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $15.89
Upside: +258.72%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $9.58
Upside: +599.37%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $56.72
Upside: -38.29%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $7.60
Upside: +1,044.74%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $7.65
Upside: +2,187.58%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $36.88
Upside: +95.23%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $9.14
Upside: +107.88%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $2.85
Upside: +1,654.39%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $0.86
Upside: +4,545.22%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.38
Upside: +4,651.85%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $14.90
Upside: +2,718.79%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $19.21
Upside: +300.83%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $65.14
Upside: +18.21%